HPS Pharmacies wish to give notice that Viatris, in consultation with the Therapeutic Goods Administration (TGA), has issued a product defect alert for Vancomycin Viatris as follows:
Vancomycin Viatris 500mg Vials
Vancomycin Viatris 1000mg Vials
This product defect alert has been issued due to a suspected packaging error. A small number of cartons labelled as Vancomycin Viatris 500mg have been found to contain vials of Vancomycin Viatris 1000mg.
Affected batches are:
- 500mg vials – batch number 7607760 (please inspect all stock as only a single batch of this strength has been distributed)
- 1000mg vials – batch number: 7607754
Stock from the above batches should be carefully examined before use to detect any discrepancies between the label on the carton and the label on the vial.
Please inspect your stock and quarantine any impacted products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All impacted products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Viatris on 1800 274 276, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates